Azioni Acerus Pharmaceuticals Corporation Toronto S.E.
Azioni
ASP
CA00444G4051
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/05/18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17/07/20 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09/09/13 |
Borys Chabursky
BRD | Director/Board Member | - | 20/12/15 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+62,66% | 854 Mrd | |
+40,42% | 636 Mrd | |
-4,37% | 361 Mrd | |
+17,16% | 324 Mrd | |
+9,87% | 301 Mrd | |
+15,66% | 247 Mrd | |
+4,21% | 230 Mrd | |
+17,90% | 228 Mrd | |
+14,86% | 177 Mrd |